Comparison of Sphatika Churn and Yavagrajadi Gutika in the management of Tundikeri

Parallel comparative clinical study of Sphatika churn and Yavagrajadi gutika in the management of Tundikeri

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023587

Enrollment

Registered

2020-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J039- Acute tonsillitis, unspecified

Interventions

Intervention1: Sphatika churna: Sphatika Churna 150mg - 300mg Twice a day with lukewarm water after meal for 7 days Control Intervention1: Yavagrajadi gutika: Yavagrajadi guyika 250mg - 500mg Twice a

Eligibility

Inclusion criteria

Inclusion criteria: Patient suffering from acute attack of Tundikeri

Exclusion criteria

Exclusion criteria: 1. Patients with peritonsillar abscess, tonsillar cyst, tonsilolith. 2. Patient with any other systemic disorder. 3. Patient with any congenital or hereditary disorder. 4. Other conditions which mimic tonsillitis e.g. Diphtheria, Herpes, etc.

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of Shpatika churna and Yavagrajadi gutika in the management of Tundikeri.Timepoint: 24 weeks	—

Secondary

Measure	Time frame
To study the efficacy of Sphatika churna in the management of TundikeriTimepoint: 24 weeks	—

Countries

India

Contacts

Public ContactDr Vicky Dalvi

Hon.shree Annasaheb Dange Ayurvedic Medical College and Post graduation research centre Ashta

ayuabhi108@gmail.com8149980338

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026